Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial.

Zander, Thilo; Pabst, Thomas; Schär, Sämi; Aebi, Stefan; Mey, Ulrich; Novak, Urban; Lerch, Erika; Rhyner Agocs, Gaëlle; Goede, Jeroen; Maniecka, Zuzanna; Hayoz, Stefanie; Rüfer, Axel; Renner, Christoph; Driessen, Christoph (2023). Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial. Leukemia, 37(3), pp. 699-701. Springer Nature 10.1038/s41375-023-01809-z

[img]
Preview
Text
s41375-023-01809-z.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (420kB) | Preview

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

UniBE Contributor:

Pabst, Thomas Niklaus, Novak, Urban

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1476-5551

Publisher:

Springer Nature

Language:

English

Submitter:

Pubmed Import

Date Deposited:

19 Jan 2023 08:26

Last Modified:

25 Mar 2024 10:01

Publisher DOI:

10.1038/s41375-023-01809-z

PubMed ID:

36635391

BORIS DOI:

10.48350/177355

URI:

https://boris.unibe.ch/id/eprint/177355

Actions (login required)

Edit item Edit item
Provide Feedback